Grand Opening of Avirmax CMC Inc’s Gene Therapy CDMO Facility

Avirmax CMC Inc., an invaluable resource for accelerating AAV gene therapy research and development Tweet this Avirmax CMC Inc. has exemplary expertise in AAV vector design, engineering, process development, GMP manufacturing, analytical testing and characterization that enable clients to obtain full services in AAV product supply from transgene DNA sequences into final AAV final products. … Read more

Precision Optics Reports Third Quarter Fiscal Year 2023 Financial Results

Conference Call Scheduled for today, May 15, 2023 at 5:00pm ET GARDNER, Mass., May 15, 2023 /PRNewswire/ — Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced operating results on an unaudited basis for its third quarter fiscal year 2023. Third quarter … Read more

Players Include Honeywell International, DuPont de Nemours, 3M, Kimberly-Clark and Ansell

DUBLIN, May 15, 2023 /PRNewswire/ — The “Global Personal Protective Equipment (PPE) Market Outlook to 2028” report has been added to  ResearchAndMarkets.com’s offering. This report provides deep insight into the current and future state of the Personal protective equipment market across various regions. The report examines the market drivers and restraints, along with the impact … Read more

RedHill Biopharma Receives NASDAQ Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency

TEL AVIV, Israel and RALEIGH, N.C., May 15, 2023 /PRNewswire/ —  RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that it has received a written notification (the “Notification Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) dated May 9, 2023 indicating that the Company is not in compliance with … Read more

Lucid Diagnostics Provides Business Update and First Quarter Financial Results

EsoGuard® test volume increases 57 percent sequentially and 245 percent year-on-year Conference call and webcast to be held tomorrow, May 16th at 8:30 AM EST NEW YORK, May 15, 2023 /PRNewswire/ — Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”) a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ( “PAVmed”), … Read more

Increasing Popularity of Fortified Food Products Drives Growth

DUBLIN, May 15, 2023 /PRNewswire/ — The “Global Vitamin D Market 2023-2030” report has been added to  ResearchAndMarkets.com’s offering. The global vitamin D market is expected to witness a growth trend at a CAGR of 7.51% during the forecast period 2023-2030. Factors such as the growing use of dietary supplements, multiple applications of vitamin D … Read more

Champions for Children

Lorestry announces global partners search CONCORD, Mass., May 15, 2023 /PRNewswire/ — Lorestry, by Alea Diagnostics (Alea) has just announced their search for mission-driven global partners committed to high quality health outcomes for newborns, children, and families. The pediatric nurse-led company is a trusted data gathering and developmental care navigation resource for parents, and is … Read more

Neptune Wellness Solutions Inc. Closes US$4 Million Public Offering

LAVAL, QC & JUPITER, Fla., May 15, 2023 /PRNewswire/ – Neptune Wellness Solutions Inc. (“Neptune” or the “Company”) (NASDAQ: NEPT), a consumer-packaged goods company focused on plant-based, sustainable and purpose-driven lifestyle brands, today announced that it has closed the previously announced public offering of 12,121,212 of its common shares (or common share equivalents in lieu thereof) … Read more

NUTEX HEALTH REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS

NET REVENUE OF $56.3 MILLION NET CASH FROM OPERATING ACTIVITIES OF $1.1 MILLION  COMPANY EXPECTS TO OPEN 4-5 MORE HOSPITALS IN 2023 AND ANOTHER 14 BY END OF 2025 HOUSTON, May 15, 2023 /PRNewswire/ — Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 19 … Read more

SenesTech to Participate at Lytham Partners Spring 2023 Investor Conference on May 18, 2023

PHOENIX, May 15, 2023 /PRNewswire/ — SenesTech, Inc. (NASDAQ: SNES) (www.senestech.com) the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, ContraPest®, today announced Joel Fruendt, CEO, will participate in a fireside chat and host one-on-one meetings with investors at the Lytham Partners Spring 2023 Investor Conference, taking … Read more